Immunovia AB (publ) (LON:0G8X)
0.418
-0.014 (-3.24%)
At close: Feb 13, 2025
Immunovia AB Market Cap
Immunovia AB has a market cap or net worth of 8.17 million as of February 21, 2025. Its market cap has increased by 38.16% in one year.
Market Cap
8.17M
Enterprise Value
4.25M
Revenue
46.49K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.42
Market Cap Chart
Since December 1, 2015, Immunovia AB's market cap has decreased from 32.41M to 8.17M, a decrease of -74.80%. That is a compound annual growth rate of -13.87%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
AstraZeneca | 181.54B |
GSK plc | 58.32B |
Haleon | 35.36B |
Smith & Nephew | 9.01B |
Hikma Pharmaceuticals | 5.12B |
ConvaTec Group | 5.06B |
HUTCHMED (China) | 2.19B |
Genus | 1.17B |